NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,000 | +100.0% | 6,434 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | -75.0% | 6,434 | -79.0% | 0.00% | – |
| Q1 2020 | $12,000 | -36.8% | 30,618 | -3.8% | 0.00% | – |
| Q4 2019 | $19,000 | -5.0% | 31,815 | -0.8% | 0.00% | – |
| Q3 2019 | $20,000 | -41.2% | 32,081 | -4.4% | 0.00% | – |
| Q2 2019 | $34,000 | -57.5% | 33,544 | +69.2% | 0.00% | – |
| Q1 2019 | $80,000 | +142.4% | 19,823 | -4.5% | 0.00% | – |
| Q4 2018 | $33,000 | -66.3% | 20,747 | -1.3% | 0.00% | – |
| Q3 2018 | $98,000 | -31.5% | 21,011 | +2.9% | 0.00% | – |
| Q2 2018 | $143,000 | +78.8% | 20,417 | +29.6% | 0.00% | – |
| Q1 2018 | $80,000 | +21.2% | 15,753 | -2.0% | 0.00% | – |
| Q4 2017 | $66,000 | -19.5% | 16,082 | +2.4% | 0.00% | – |
| Q3 2017 | $82,000 | -13.7% | 15,698 | -3.3% | 0.00% | – |
| Q2 2017 | $95,000 | – | 16,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |